Modafinil augmentation of mirtazapine in a failure-to-thrive geriatric inpatient

International Journal of Psychiatry in Medicine

Volumn 32, Issue 4, 2002, Pages 405-410

  Schillerstrom, Jason E ^a   Seaman, Jeff S ^b  

^a University of Texas Health Science Center at San Antonio   (United States)

^b NONE

Author keywords

Failure to thrive; Geriatrics; Mirtazapine; Modafinil

Indexed keywords

MIRTAZAPINE; MODAFINIL;

AGED; AGING; ANOREXIA; APATHY; ARTICLE; CASE REPORT; COGNITIVE DEFECT; DEPRESSION; DRUG POTENTIATION; FAILURE TO THRIVE; HUMAN; MALE; MULTIPLE MYELOMA; PSYCHOSOCIAL WITHDRAWAL; TREATMENT OUTCOME; TREATMENT PLANNING;

AGED; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BENZHYDRYL COMPOUNDS; CACHEXIA; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION DISORDERS; DEPRESSIVE DISORDER, MAJOR; DRUG THERAPY, COMBINATION; FRAIL ELDERLY; HOSPITALIZATION; HUMANS; MALE; MIANSERIN;

EID: 0038304432     PISSN: 00912174     EISSN: None     Source Type: Journal    
DOI: 10.2190/J82T-B61G-7DHD-4PW5     Document Type: Article

References (14)

1. Verdery RB. Failure to thrive in the elderly. Clinics in Geriatric Medicine 1995;11:653-659.
2. Palmer RM. 'Failure to Thrive' in the elderly: Diagnosis and management. Geriatrics 1990;45:47-55.
3. Berkman B, Foster LW, Campion E. Failure to thrive: Paradigm for the frail elder. Gerontologist 1989;29:654-659.
4. Wallace JI, Schwartz RS, LaCroix AZ, Uhlmann RF, Pearlman RA. Involuntary weight loss in older outpatients: Incidence and clinical significance. Journal of the American Geriatrics Society 1995;43:329-337.
5. Wallace AE, Kofoed LL, Weat AN. Double blind placebo controlled trial of methylphenidate in older, depressed, medically ill patients. The American Journal of Psychiatry 1995;152:929-931.
6. Masand P, Pickett P, Murray GB. Psychostimulants for secondary depression in medical illness. Psychosomatics 1991;32:203-208.
7. Masand OJ. Psychostimulants for depression in hospitalized cancer patients. Psychosomatics 1996;37:57-62.
8. Engber TM, Dennis SA, Jones BE, Miller MS, Contreras PC. Brain regional substrates for the actions of the novel wake promoting agent modafinil in the rat: A comparison with amphetamine. Neuroscience 1998;87:905-911.
9. Scammel TE, Estabrooke IV, McCarthy MT, Chemelli RM, Yanagisawa M, Miller MS, Saper CB. Hypothalamic arousal regions are activated during modafinil-induced wakefulness. Journal of Neuroscience 2000;20:8620-8628.
10. Menza MA, Kaufman KR, Castellanos A. Modafinil augmentation of antidepressant treatment in depression. Journal of Clinical Psychiatry 2000;61:378-381
11. Fawcett J, Barkin RL. Review of the results from clinical studies on the efficacy, safety, and tolerability of mirtazapine for the treatment of patients with major depression. Journal of Affective Disorders 1998;51:267-285
12. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975;12:189-198
13. Royall DR, Cordes JA, Polk M. CLOX: An executive clock drawing task. Journal of Neurology, Neurosurgery, and Psychiatry 1998;64:588-594
14. Raji MA, Brady SR. Mirtazapine for treatment of depression and comorbidities in Alzheimer Disease. Annals of Pharmacotherapy 2001;35:1024-1027.